Stock ZBH ZIMMER BIOMET HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Zimmer Biomet Holdings, Inc.

Equities

ZBH

US98956P1021

Medical Equipment, Supplies & Distribution

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-26 pm EDT 		5-day change 1st Jan Change
119.4 USD -0.33% Intraday chart for Zimmer Biomet Holdings, Inc. -0.07% -1.93%
Apr. 15 Truist Securities Adjusts Zimmer Biomet Price Target to $137 From $135, Hold Rating Kept MT
Apr. 04 Zimmer Biomet Partners with Three Pickleball Organizations in US MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 30,787 31,940 26,540 26,756 25,433 24,522 - -
Enterprise Value (EV) 1 38,390 39,264 33,130 32,077 30,785 28,450 27,117 26,630
P/E ratio 27.4 x -230 x 66.5 x 116 x 24.9 x 22.8 x 20.3 x 18 x
Yield 0.64% 0.62% 0.76% 0.75% 0.79% 0.88% 0.87% 0.94%
Capitalization / Revenue 3.86 x 4.55 x 3.39 x 3.86 x 3.44 x 3.17 x 3.03 x 2.9 x
EV / Revenue 4.81 x 5.59 x 4.23 x 4.62 x 4.16 x 3.67 x 3.35 x 3.15 x
EV / EBITDA 14.7 x 19.2 x 13.3 x 14 x 12.4 x 10.6 x 9.76 x 9.59 x
EV / FCF 36.1 x 49.4 x 32.3 x 35.2 x 31.5 x 23.6 x 16.6 x 15.3 x
FCF Yield 2.77% 2.03% 3.1% 2.84% 3.18% 4.24% 6.02% 6.54%
Price to Book 2.49 x 2.62 x 2.1 x 2.22 x 2 x 1.77 x 1.59 x -
Nbr of stocks (in thousands) 205,684 207,278 208,909 209,852 208,981 205,461 - -
Reference price 2 149.7 154.1 127.0 127.5 121.7 119.4 119.4 119.4
Announcement Date 2/4/20 2/5/21 2/7/22 2/3/23 2/8/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 7,982 7,024 7,836 6,940 7,394 7,744 8,104 8,445
EBITDA 1 2,610 2,044 2,487 2,293 2,477 2,673 2,778 2,777
EBIT 1 2,188 1,609 2,035 1,894 2,087 2,243 2,386 2,528
Operating Margin 27.42% 22.91% 25.97% 27.29% 28.22% 28.97% 29.44% 29.93%
Earnings before Tax (EBT) 1 905.8 -274.4 418.4 403.5 1,067 1,268 1,439 1,534
Net income 1 1,132 -138.9 401.6 231.4 1,024 1,053 1,204 1,332
Net margin 14.18% -1.98% 5.12% 3.33% 13.85% 13.6% 14.86% 15.77%
EPS 2 5.470 -0.6700 1.910 1.100 4.880 5.237 5.881 6.618
Free Cash Flow 1 1,063 795.3 1,025 910 978.8 1,206 1,632 1,741
FCF margin 13.31% 11.32% 13.09% 13.11% 13.24% 15.57% 20.14% 20.61%
FCF Conversion (EBITDA) 40.72% 38.91% 41.23% 39.68% 39.51% 45.12% 58.75% 62.68%
FCF Conversion (Net income) 93.92% - 255.33% 393.26% 95.59% 114.48% 135.49% 130.68%
Dividend per Share 2 0.9600 0.9600 0.9600 0.9600 0.9600 1.046 1.044 1.120
Announcement Date 2/4/20 2/5/21 2/7/22 2/3/23 2/8/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 1,924 2,038 1,663 1,782 1,670 1,825 1,831 1,870 1,754 1,940 1,868 1,962 1,863 2,062 1,953
EBITDA 1 613.2 642.2 542.2 597.9 748 613.9 618.7 613.6 560 684.8 632 667.5 627.5 745.8 634.2
EBIT 1 501.8 527 439.2 498.2 439.5 516.9 520.3 514.3 463.8 588.5 523.7 565 522.2 632.9 554.2
Operating Margin 26.08% 25.86% 26.41% 27.96% 26.32% 28.32% 28.42% 27.51% 26.45% 30.33% 28.04% 28.8% 28.03% 30.7% 28.37%
Earnings before Tax (EBT) 1 162.6 -138.7 101.2 199.5 478.3 -74.8 286.8 276.8 219.2 284.4 264.5 341.5 289.8 387.4 292.7
Net income 1 145.6 -84 14.2 153.7 361.9 -130.5 232.5 209.6 162.7 419.2 229.2 274.4 233.2 323.8 279.2
Net margin 7.57% -4.12% 0.85% 8.63% 21.67% -7.15% 12.7% 11.21% 9.28% 21.61% 12.27% 13.98% 12.52% 15.7% 14.29%
EPS 2 0.6900 -0.4000 0.0700 0.7300 1.720 -0.6200 1.110 1.000 0.7700 2.010 1.166 1.354 1.173 1.616 1.347
Dividend per Share 2 0.2400 0.2400 0.2400 0.2400 0.2400 0.2400 0.2400 0.2400 - 0.2400 0.2428 0.2426 0.2421 0.2422 0.2471
Announcement Date 11/4/21 2/7/22 5/3/22 8/2/22 11/2/22 2/3/23 5/2/23 8/1/23 11/7/23 2/8/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 7,604 7,324 6,590 5,321 5,352 3,928 2,595 2,108
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.913 x 3.583 x 2.65 x 2.32 x 2.161 x 1.47 x 0.9344 x 0.7589 x
Free Cash Flow 1 1,063 795 1,025 910 979 1,206 1,632 1,741
ROE (net income / shareholders' equity) 13.7% 9.61% 12.5% 11.7% 12.9% 12.8% 12.8% 17.2%
ROA (Net income/ Total Assets) 6.67% 4.82% 6.48% 6.51% 7.44% 7.76% 8.25% 12.8%
Assets 1 16,965 -2,883 6,202 3,555 13,756 13,583 14,590 10,393
Book Value Per Share 2 60.10 58.70 60.60 57.50 60.70 67.50 74.90 -
Cash Flow per Share 2 7.670 5.820 7.130 6.450 7.540 9.710 11.00 12.10
Capex 1 523 409 474 446 603 595 641 713
Capex / Sales 6.55% 5.83% 6.05% 6.43% 8.15% 7.68% 7.91% 8.44%
Announcement Date 2/4/20 2/5/21 2/7/22 2/3/23 2/8/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Zimmer Biomet Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
119.4 USD
Average target price
137.1 USD
Spread / Average Target
+14.91%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-1.93% 24.52B
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. ZBH Stock
  4. Financials Zimmer Biomet Holdings, Inc.